 CAMBRIDGE, Mass., June 16, 2022 GLOBE NEWSWIRE -- Relay Therapeutics, Inc. Nasdaq: RLAY, a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced registration is open for the virtual analyst and investor event on June 27, 2022 from 8:00 a.m. to 9:00 a.m. ET. 